Cancer Cell Paper Identifies “Avidity Enhancement” As New Strategy for Improving CAR T Therapy for Acute Myeloid Leukemia
Research Revealed Through Cell Avidity Measurement Demonstrates Superior Tumor Clearance In Vivo Due To “Avidity Enhancement” AMSTERDAM, May 24, 2022 /PRNewswire/ — LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity…
Comments Off on Cancer Cell Paper Identifies “Avidity Enhancement” As New Strategy for Improving CAR T Therapy for Acute Myeloid Leukemia